MINNEAPOLIS--(BUSINESS WIRE)--March 23, 2006--An independent arbitration panel has found in favor of Medtronic, Inc. (NYSE:MDT) in a case in which Johnson & Johnson/Cordis alleged that the Medtronic Driver(TM) stent and several other Medtronic stents infringed certain Cordis patents. The arbitration panel issued its non-appealable decision on February 20 and the award became final on March 22.
